Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Wockhardt Ltd.
₹1,267.50
Invest in WOCKPHARMA with up to 2.22x margin.
Trade with MTF₹1198.40
₹1283.50
₹1154.40
₹1868.80
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 430 | 380 | 413 | 355 | 325 |
| Operating Expense | 317 | 267 | 282 | 249 | 263 |
| Operating Profit | 113 | 113 | 131 | 106 | 62 |
| Depreciation | 52 | 45 | 46 | 40 | 42 |
| Interest | 50 | 44 | 41 | 40 | 48 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 28 | 54 | 69 | 40 | -22 |
₹1267.50
↗ Bullish Moving Average
1
↘ Bearish Moving Average
15
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 52 | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 |
| FII | 6.7 | 6.5 | 6.8 | 7.3 | 7.1 | 7 |
| DII | 5.1 | 9.9 | 10.6 | 11 | 11 | 10.6 |
| Public | 36.2 | 34.5 | 33.5 | 32.6 | 32.8 | 33.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 5.29 L | 13.91 L | 38.04% |
| Week | 5.39 L | 15.06 L | 35.76% |
| 1 Month | 2.99 L | 7.37 L | 40.62% |
| 6 Month | 2.44 L | 9.51 L | 25.70% |
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Companies with decreasing Promoter pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 17 Nov, 2016 | 10 | INTERIM | 19 Nov, 2016 | Equity Share |
| 13 Nov, 2014 | 20 | INTERIM | 15 Nov, 2014 | Equity Share |
| 17 Feb, 2014 | 5 | INTERIM | 19 Feb, 2014 | Equity Share |
| 07 Nov, 2013 | 5 | INTERIM | 08 Nov, 2013 | Equity Share |
| 22 Aug, 2013 | 5 | FINAL | Equity Share | |
| 17 Apr, 2008 | 2.5 | FINAL | Equity Share | |
| 26 Oct, 2007 | 8.75 | INTERIM | 29 Oct, 2007 | Equity Share |
| 22 Mar, 2007 | 5 | FINAL | 23 Mar, 2007 | Equity Share |
| 21 Jun, 2006 | 5 | FINAL | Equity Share | |
| 12 Apr, 2005 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,560.70 | ₹607.80 | ₹781.35 | ₹2,333 | ₹997 | ₹309.80 |
| % Change | 0.30% | 2.57% | 1.11% | -8.82% | 2.50% | 2.77% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,215.10 | ₹2,512.26 | ₹2,051.45 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹286.98 | ₹543.69 | ₹201.69 |
| PE TTM | - | - | 61.70 | 73.00 | 22.00 | 57.20 |
| 1 Year Return | 46.52 | -0.08 | 59.34 | 109.65 | -10.03 | -73.81 |
| ROCE | 30.24 | 34.78 | 34.76 | 16.50 | - | 13.36 |
Eris Lifesciences Ltd.
₹ 1303.00
+0.45%
Syngene International Ltd.
₹ 395.00
+1.31%
Alembic Pharmaceuticals Ltd.
₹ 673.30
+1.52%
Strides Pharma Science Ltd.
₹ 967.90
+3.22%
Granules India Ltd.
₹ 630.45
+1.62%
FDC Ltd.
₹ 331.65
+3.29%
Shilpa Medicare Ltd.
₹ 374.80
+7.42%
Jubilant Pharmova Ltd.
₹ 819.15
+0.33%
Natco Pharma Ltd.
₹ 1000.35
+2.68%
Caplin Point Laboratories Ltd.
₹ 1583.30
+5.22%
Neuland Laboratories Ltd.
₹ 12650.00
+5.18%
Marksans Pharma Ltd.
₹ 169.59
+8.09%
Sanofi India Ltd.
₹ 3257.20
+1.48%
Procter & Gamble Health Ltd.
₹ 4826.70
+0.58%
Jeena Sikho Lifecare Ltd.
₹ 584.15
+8.24%
OneSource Specialty Pharma Ltd.
₹ 1469.30
-0.27%
Sanofi Consumer Healthcare India Ltd.
₹ 4508.00
+4.88%
Akums Drugs & Pharmaceuticals Ltd.
₹ 496.15
+6.45%
Blue Jet Healthcare Ltd
₹ 353.65
+8.07%
Concord Biotech Ltd.
₹ 1023.50
+0.50%
Aarti Pharmalabs Ltd.
₹ 635.95
+7.43%
Piramal Pharma Ltd.
₹ 142.47
+4.34%
By signing up I certify terms, conditions & privacy policy